Related Experiment Videos
Soluble intercellular adhesion molecule-1 levels in patients with psoriasis
R E Schopf1, S Naumann, M Rehder
1Department of Dermatology, Johannes Gutenberg University, Mainz, Germany.
The British Journal of Dermatology
|January 1, 1993
Summary
Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) are elevated in psoriasis vulgaris patients compared to healthy individuals. These sICAM-1 levels correlate with psoriasis severity, suggesting a role in inflammatory processes.
Area of Science:
- Immunodermatology
- Biomarker Discovery
- Inflammation Research
Background:
- Psoriasis vulgaris is a chronic inflammatory skin condition.
- Intercellular Adhesion Molecule-1 (ICAM-1) plays a role in immune cell trafficking.
- Soluble ICAM-1 (sICAM-1) may serve as a circulating biomarker for inflammation.
Purpose of the Study:
- To quantify serum sICAM-1 levels in patients with psoriasis vulgaris.
- To compare sICAM-1 levels between psoriatic patients and healthy controls.
- To investigate the correlation between sICAM-1 levels and psoriasis severity.
Main Methods:
- Enzyme-Linked Immunosorbent Assay (ELISA) was developed to detect sICAM-1.
- Serum samples from 17 psoriatic patients and 17 age/sex-matched controls were analyzed.
- Psoriasis Area and Severity Index (PASI) was used to assess disease extent.
Main Results:
- Mean serum sICAM-1 levels were significantly higher in psoriatic patients (480.5 +/- 133.6 ng/ml) than in controls (358.8 +/- 87.9 ng/ml) (P = 0.02).
- Serum sICAM-1 levels showed a direct positive correlation with the PASI score (y = 363.002 + 8.525x, R = 0.55, P = 0.021).
Conclusions:
- Serum sICAM-1 concentration is elevated in psoriasis vulgaris.
- Increased sICAM-1 levels are associated with the severity of psoriatic skin lesions.
- Further research is needed to define the origin and function of sICAM-1 in psoriasis pathogenesis.